Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
tau Proteins | 94 | 2024 | 1860 | 8.580 |
Why?
|
Alzheimer Disease | 181 | 2024 | 7988 | 8.580 |
Why?
|
Amyloid beta-Peptides | 134 | 2023 | 3574 | 7.960 |
Why?
|
Positron-Emission Tomography | 191 | 2024 | 6259 | 5.730 |
Why?
|
Aniline Compounds | 66 | 2023 | 983 | 4.180 |
Why?
|
Carbolines | 26 | 2024 | 265 | 3.890 |
Why?
|
Amyloid | 38 | 2023 | 795 | 3.880 |
Why?
|
Brain | 133 | 2024 | 26343 | 3.140 |
Why?
|
Thiazoles | 57 | 2019 | 1484 | 2.820 |
Why?
|
Aging | 42 | 2020 | 8626 | 2.460 |
Why?
|
Amyloidogenic Proteins | 11 | 2023 | 151 | 2.110 |
Why?
|
Memory Disorders | 20 | 2023 | 1183 | 1.980 |
Why?
|
Cerebral Cortex | 30 | 2023 | 5705 | 1.930 |
Why?
|
Tauopathies | 11 | 2024 | 307 | 1.920 |
Why?
|
Radiopharmaceuticals | 31 | 2020 | 2658 | 1.880 |
Why?
|
Apathy | 8 | 2019 | 96 | 1.650 |
Why?
|
Hippocampus | 19 | 2020 | 3661 | 1.610 |
Why?
|
Amyloidosis | 14 | 2023 | 795 | 1.490 |
Why?
|
Presenilin-1 | 13 | 2023 | 635 | 1.360 |
Why?
|
Neural Pathways | 12 | 2021 | 2971 | 1.360 |
Why?
|
Neuropsychological Tests | 44 | 2021 | 6974 | 1.310 |
Why?
|
Brain Mapping | 30 | 2023 | 6669 | 1.270 |
Why?
|
Plaque, Amyloid | 11 | 2023 | 729 | 1.260 |
Why?
|
Memory | 15 | 2023 | 2163 | 1.250 |
Why?
|
Cerebral Amyloid Angiopathy | 12 | 2022 | 855 | 1.240 |
Why?
|
Nerve Net | 15 | 2021 | 2174 | 1.210 |
Why?
|
Temporal Lobe | 17 | 2023 | 1669 | 1.160 |
Why?
|
Aged, 80 and over | 120 | 2023 | 57683 | 1.150 |
Why?
|
Lewy Body Disease | 7 | 2020 | 226 | 1.150 |
Why?
|
Activities of Daily Living | 12 | 2023 | 2414 | 1.130 |
Why?
|
Cognition | 29 | 2023 | 6722 | 1.130 |
Why?
|
Aged | 198 | 2023 | 162944 | 1.110 |
Why?
|
Dementia | 11 | 2017 | 2501 | 1.050 |
Why?
|
Fluorine Radioisotopes | 10 | 2019 | 448 | 1.030 |
Why?
|
Fluorodeoxyglucose F18 | 17 | 2018 | 2013 | 1.010 |
Why?
|
Cognition Disorders | 19 | 2018 | 4030 | 1.000 |
Why?
|
Apolipoprotein E4 | 18 | 2023 | 667 | 0.990 |
Why?
|
Entorhinal Cortex | 11 | 2023 | 264 | 0.910 |
Why?
|
Longitudinal Studies | 56 | 2023 | 13921 | 0.890 |
Why?
|
Magnetic Resonance Imaging | 101 | 2023 | 35342 | 0.880 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2021 | 997 | 0.850 |
Why?
|
Ethylene Glycols | 10 | 2019 | 156 | 0.840 |
Why?
|
Male | 213 | 2023 | 349538 | 0.820 |
Why?
|
Humans | 299 | 2024 | 742088 | 0.780 |
Why?
|
Female | 210 | 2023 | 379592 | 0.770 |
Why?
|
Image Processing, Computer-Assisted | 29 | 2023 | 8925 | 0.720 |
Why?
|
Aphasia, Primary Progressive | 5 | 2020 | 73 | 0.710 |
Why?
|
Parahippocampal Gyrus | 1 | 2020 | 116 | 0.700 |
Why?
|
Models, Neurological | 10 | 2021 | 1771 | 0.660 |
Why?
|
Disease Progression | 33 | 2023 | 13256 | 0.650 |
Why?
|
Cross-Sectional Studies | 51 | 2023 | 24913 | 0.650 |
Why?
|
Football | 4 | 2023 | 460 | 0.610 |
Why?
|
Speech Perception | 5 | 2023 | 489 | 0.590 |
Why?
|
Parkinson Disease | 8 | 2020 | 2774 | 0.560 |
Why?
|
Heterozygote | 11 | 2023 | 2790 | 0.560 |
Why?
|
Middle Aged | 117 | 2023 | 213127 | 0.560 |
Why?
|
Atrophy | 12 | 2023 | 1576 | 0.560 |
Why?
|
Nuclear Medicine | 3 | 2013 | 233 | 0.540 |
Why?
|
Locus Coeruleus | 5 | 2023 | 176 | 0.540 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2019 | 269 | 0.520 |
Why?
|
Choroid Plexus | 1 | 2018 | 231 | 0.510 |
Why?
|
Isoquinolines | 3 | 2024 | 368 | 0.510 |
Why?
|
Neurodegenerative Diseases | 5 | 2024 | 1060 | 0.500 |
Why?
|
Mental Status Schedule | 9 | 2017 | 321 | 0.490 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 6 | 2013 | 1107 | 0.490 |
Why?
|
Appointments and Schedules | 1 | 2017 | 414 | 0.470 |
Why?
|
Neocortex | 2 | 2017 | 400 | 0.460 |
Why?
|
Leukoaraiosis | 3 | 2022 | 120 | 0.430 |
Why?
|
Apolipoproteins E | 9 | 2023 | 1438 | 0.430 |
Why?
|
Verbal Learning | 4 | 2014 | 466 | 0.430 |
Why?
|
Mood Disorders | 2 | 2016 | 1106 | 0.420 |
Why?
|
Community Health Services | 1 | 2017 | 650 | 0.420 |
Why?
|
Stilbenes | 1 | 2013 | 156 | 0.410 |
Why?
|
Mental Recall | 7 | 2020 | 1205 | 0.410 |
Why?
|
Speech Acoustics | 3 | 2019 | 151 | 0.400 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2019 | 422 | 0.400 |
Why?
|
Auditory Cortex | 3 | 2023 | 346 | 0.390 |
Why?
|
Peptide Fragments | 10 | 2023 | 5095 | 0.390 |
Why?
|
Mental Processes | 1 | 2012 | 249 | 0.380 |
Why?
|
Molecular Imaging | 3 | 2017 | 831 | 0.380 |
Why?
|
Speech | 4 | 2023 | 540 | 0.380 |
Why?
|
Sensation | 1 | 2012 | 337 | 0.370 |
Why?
|
Linear Models | 15 | 2019 | 5948 | 0.370 |
Why?
|
Corpus Striatum | 4 | 2019 | 1220 | 0.360 |
Why?
|
Psychosurgery | 1 | 2009 | 87 | 0.340 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1372 | 0.340 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2017 | 1872 | 0.330 |
Why?
|
Protozoan Infections, Animal | 1 | 2008 | 5 | 0.320 |
Why?
|
Central Nervous System Protozoal Infections | 1 | 2008 | 6 | 0.320 |
Why?
|
Phonetics | 6 | 2023 | 206 | 0.320 |
Why?
|
Oncorhynchus mykiss | 1 | 2008 | 24 | 0.320 |
Why?
|
Fish Diseases | 1 | 2008 | 38 | 0.310 |
Why?
|
Diagnostic Self Evaluation | 4 | 2017 | 230 | 0.310 |
Why?
|
Seizures | 2 | 2020 | 2851 | 0.310 |
Why?
|
Benzothiazoles | 5 | 2017 | 247 | 0.310 |
Why?
|
Eukaryota | 1 | 2008 | 100 | 0.300 |
Why?
|
Patient Compliance | 1 | 2017 | 2680 | 0.290 |
Why?
|
Psychomotor Performance | 6 | 2019 | 1895 | 0.290 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2018 | 6030 | 0.290 |
Why?
|
Chromatography, Ion Exchange | 1 | 2006 | 305 | 0.280 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 2010 | 403 | 0.280 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 1808 | 0.270 |
Why?
|
Loneliness | 2 | 2018 | 184 | 0.270 |
Why?
|
Mutation | 12 | 2023 | 29717 | 0.260 |
Why?
|
Epilepsy | 3 | 2020 | 3301 | 0.260 |
Why?
|
Motor Activity | 2 | 2015 | 2714 | 0.260 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 276 | 0.260 |
Why?
|
Autoradiography | 4 | 2019 | 749 | 0.260 |
Why?
|
Executive Function | 6 | 2017 | 1362 | 0.260 |
Why?
|
Apolipoprotein E3 | 3 | 2022 | 97 | 0.250 |
Why?
|
Cohort Studies | 24 | 2023 | 40450 | 0.250 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2020 | 1574 | 0.250 |
Why?
|
Life Style | 2 | 2020 | 3824 | 0.250 |
Why?
|
Fellowships and Scholarships | 1 | 2013 | 1066 | 0.250 |
Why?
|
Amides | 1 | 2006 | 458 | 0.230 |
Why?
|
Sleep Apnea Syndromes | 1 | 2012 | 941 | 0.230 |
Why?
|
Adult | 43 | 2023 | 213712 | 0.230 |
Why?
|
Hypertension | 2 | 2021 | 8455 | 0.230 |
Why?
|
Perfusion | 1 | 2007 | 1359 | 0.220 |
Why?
|
Awareness | 2 | 2017 | 639 | 0.220 |
Why?
|
Oxygen | 7 | 2017 | 4169 | 0.210 |
Why?
|
Biomedical Research | 2 | 2015 | 3306 | 0.210 |
Why?
|
Intelligence | 1 | 2007 | 920 | 0.210 |
Why?
|
Learning Curve | 1 | 2023 | 200 | 0.210 |
Why?
|
Australia | 4 | 2022 | 1167 | 0.210 |
Why?
|
Depression | 6 | 2021 | 7733 | 0.210 |
Why?
|
Colombia | 2 | 2021 | 259 | 0.200 |
Why?
|
Antipsychotic Agents | 1 | 2014 | 3058 | 0.190 |
Why?
|
Psychiatry | 1 | 2013 | 1695 | 0.190 |
Why?
|
Styrene | 3 | 2005 | 24 | 0.190 |
Why?
|
Nerve Degeneration | 3 | 2020 | 748 | 0.190 |
Why?
|
Basal Ganglia Diseases | 1 | 2021 | 149 | 0.190 |
Why?
|
Supranuclear Palsy, Progressive | 2 | 2017 | 77 | 0.190 |
Why?
|
Asymptomatic Diseases | 3 | 2019 | 552 | 0.180 |
Why?
|
Autopsy | 6 | 2023 | 1006 | 0.180 |
Why?
|
Occipital Lobe | 3 | 2020 | 380 | 0.180 |
Why?
|
Widowhood | 1 | 2020 | 54 | 0.180 |
Why?
|
Carbon Radioisotopes | 4 | 2013 | 592 | 0.170 |
Why?
|
Parietal Lobe | 4 | 2017 | 837 | 0.170 |
Why?
|
Fornix, Brain | 1 | 2019 | 70 | 0.170 |
Why?
|
Diagnostic Imaging | 4 | 2016 | 3507 | 0.170 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 1 | 2019 | 53 | 0.170 |
Why?
|
Frontotemporal Lobar Degeneration | 2 | 2017 | 99 | 0.170 |
Why?
|
Scopolamine | 1 | 2019 | 99 | 0.170 |
Why?
|
Diffusion Tensor Imaging | 5 | 2021 | 2304 | 0.170 |
Why?
|
Leukoencephalopathies | 1 | 2022 | 238 | 0.170 |
Why?
|
Trigeminal Caudal Nucleus | 1 | 2018 | 18 | 0.170 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 318 | 0.170 |
Why?
|
Research Subjects | 1 | 2020 | 238 | 0.160 |
Why?
|
Cholinergic Antagonists | 1 | 2019 | 165 | 0.160 |
Why?
|
Glucuronidase | 1 | 2020 | 207 | 0.160 |
Why?
|
Cerebral Hemorrhage | 4 | 2022 | 2643 | 0.160 |
Why?
|
Sex Characteristics | 4 | 2023 | 2585 | 0.160 |
Why?
|
Amino Acid Transport Systems, Acidic | 1 | 2017 | 28 | 0.150 |
Why?
|
Mercury | 2 | 2012 | 285 | 0.150 |
Why?
|
Amacrine Cells | 1 | 2017 | 53 | 0.150 |
Why?
|
Intracranial Hemorrhages | 3 | 2015 | 854 | 0.150 |
Why?
|
Judgment | 1 | 2020 | 281 | 0.150 |
Why?
|
Technetium Tc 99m Exametazime | 3 | 2006 | 68 | 0.150 |
Why?
|
Functional Laterality | 4 | 2014 | 2290 | 0.150 |
Why?
|
Thiones | 1 | 2017 | 46 | 0.150 |
Why?
|
Social Participation | 1 | 2019 | 172 | 0.150 |
Why?
|
Body Mass Index | 3 | 2021 | 12695 | 0.150 |
Why?
|
Palmitates | 1 | 2017 | 74 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 8 | 2021 | 17400 | 0.150 |
Why?
|
Regression Analysis | 4 | 2015 | 6452 | 0.150 |
Why?
|
Agnosia | 1 | 2017 | 66 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11695 | 0.140 |
Why?
|
Reproducibility of Results | 8 | 2023 | 19862 | 0.140 |
Why?
|
Olfactory Perception | 1 | 2016 | 54 | 0.140 |
Why?
|
Truth Disclosure | 1 | 2020 | 435 | 0.140 |
Why?
|
Neurons | 3 | 2019 | 9325 | 0.140 |
Why?
|
Carbon Isotopes | 2 | 2016 | 468 | 0.140 |
Why?
|
Organ Size | 6 | 2018 | 2253 | 0.140 |
Why?
|
Semantics | 2 | 2019 | 584 | 0.140 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7276 | 0.140 |
Why?
|
Attention | 2 | 2011 | 2396 | 0.130 |
Why?
|
Benchmarking | 1 | 2022 | 1038 | 0.130 |
Why?
|
Genetic Association Studies | 3 | 2020 | 2699 | 0.130 |
Why?
|
Neurofibrillary Tangles | 3 | 2023 | 437 | 0.130 |
Why?
|
Neurites | 1 | 2017 | 380 | 0.130 |
Why?
|
Telephone | 1 | 2019 | 617 | 0.130 |
Why?
|
Health | 1 | 2018 | 390 | 0.130 |
Why?
|
Amyloid Neuropathies | 1 | 2014 | 15 | 0.130 |
Why?
|
Carotid Artery Diseases | 1 | 2022 | 882 | 0.130 |
Why?
|
Biometry | 1 | 2018 | 558 | 0.130 |
Why?
|
Immunoassay | 1 | 2018 | 752 | 0.130 |
Why?
|
Age of Onset | 3 | 2018 | 3266 | 0.130 |
Why?
|
Cues | 2 | 2017 | 868 | 0.130 |
Why?
|
Anxiety | 3 | 2018 | 4279 | 0.120 |
Why?
|
Gyrus Cinguli | 2 | 2018 | 1088 | 0.120 |
Why?
|
Immunoglobulin G | 1 | 2006 | 4554 | 0.120 |
Why?
|
Reference Values | 5 | 2016 | 4982 | 0.120 |
Why?
|
Brain Concussion | 2 | 2023 | 1318 | 0.120 |
Why?
|
Melanocytes | 1 | 2018 | 515 | 0.120 |
Why?
|
Geriatric Assessment | 3 | 2016 | 1369 | 0.120 |
Why?
|
Risk | 8 | 2020 | 9679 | 0.120 |
Why?
|
Vision, Ocular | 1 | 2017 | 463 | 0.120 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 502 | 0.120 |
Why?
|
Hallucinations | 2 | 2013 | 360 | 0.120 |
Why?
|
New South Wales | 1 | 2013 | 66 | 0.120 |
Why?
|
Presenilin-2 | 1 | 2013 | 106 | 0.120 |
Why?
|
Age Factors | 6 | 2018 | 18355 | 0.120 |
Why?
|
Brain Chemistry | 2 | 2017 | 981 | 0.110 |
Why?
|
Prospective Studies | 10 | 2023 | 53187 | 0.110 |
Why?
|
Statistics as Topic | 4 | 2016 | 2372 | 0.110 |
Why?
|
Pattern Recognition, Visual | 1 | 2019 | 823 | 0.110 |
Why?
|
Teaching Materials | 1 | 2013 | 86 | 0.110 |
Why?
|
Amygdala | 1 | 2021 | 1305 | 0.110 |
Why?
|
Tanzania | 1 | 2017 | 1344 | 0.110 |
Why?
|
Prognosis | 8 | 2021 | 29010 | 0.110 |
Why?
|
Trout | 1 | 2012 | 18 | 0.110 |
Why?
|
Follow-Up Studies | 12 | 2020 | 39004 | 0.110 |
Why?
|
Animals | 22 | 2023 | 168561 | 0.110 |
Why?
|
Computer Simulation | 4 | 2023 | 6191 | 0.110 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 780 | 0.110 |
Why?
|
Early Diagnosis | 2 | 2020 | 1184 | 0.110 |
Why?
|
Visual Cortex | 3 | 2016 | 1149 | 0.110 |
Why?
|
Olfaction Disorders | 1 | 2015 | 222 | 0.110 |
Why?
|
Young Adult | 12 | 2020 | 56350 | 0.110 |
Why?
|
Visual Pathways | 1 | 2016 | 565 | 0.110 |
Why?
|
Pyridines | 1 | 2024 | 2818 | 0.100 |
Why?
|
Models, Theoretical | 3 | 2019 | 3584 | 0.100 |
Why?
|
Frontotemporal Dementia | 1 | 2015 | 246 | 0.100 |
Why?
|
Cricetulus | 2 | 2020 | 817 | 0.100 |
Why?
|
Isotope Labeling | 1 | 2013 | 414 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1499 | 0.100 |
Why?
|
Genetic Variation | 2 | 2020 | 6540 | 0.100 |
Why?
|
Vocal Cords | 1 | 2016 | 528 | 0.100 |
Why?
|
Apolipoprotein E2 | 2 | 2023 | 127 | 0.100 |
Why?
|
Body Burden | 1 | 2011 | 158 | 0.100 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2012 | 197 | 0.100 |
Why?
|
CHO Cells | 2 | 2020 | 1407 | 0.090 |
Why?
|
Phosphorylation | 3 | 2017 | 8436 | 0.090 |
Why?
|
Microcirculation | 1 | 2015 | 1285 | 0.090 |
Why?
|
Radioisotopes | 1 | 2012 | 499 | 0.090 |
Why?
|
Family Practice | 1 | 2013 | 516 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2018 | 3328 | 0.090 |
Why?
|
Habituation, Psychophysiologic | 1 | 2011 | 154 | 0.090 |
Why?
|
Cerebral Infarction | 1 | 2015 | 1007 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1887 | 0.090 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 1310 | 0.090 |
Why?
|
Alleles | 2 | 2019 | 6931 | 0.090 |
Why?
|
Professional Competence | 1 | 2013 | 448 | 0.090 |
Why?
|
Cricetinae | 2 | 2020 | 2471 | 0.090 |
Why?
|
Case-Control Studies | 8 | 2022 | 21719 | 0.090 |
Why?
|
Predictive Value of Tests | 6 | 2014 | 15056 | 0.090 |
Why?
|
Radionuclide Imaging | 4 | 2015 | 2027 | 0.090 |
Why?
|
Association Learning | 1 | 2011 | 224 | 0.090 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14720 | 0.090 |
Why?
|
Genotype | 7 | 2021 | 12946 | 0.090 |
Why?
|
Receptors, Immunologic | 1 | 2015 | 1423 | 0.080 |
Why?
|
Analysis of Variance | 3 | 2014 | 6365 | 0.080 |
Why?
|
Aeromonas salmonicida | 1 | 2008 | 5 | 0.080 |
Why?
|
Advisory Committees | 1 | 2013 | 773 | 0.080 |
Why?
|
Spores, Protozoan | 1 | 2008 | 6 | 0.080 |
Why?
|
Geriatrics | 1 | 2013 | 396 | 0.080 |
Why?
|
Idaho | 1 | 2008 | 16 | 0.080 |
Why?
|
Congresses as Topic | 1 | 2013 | 764 | 0.080 |
Why?
|
R Factors | 1 | 2008 | 44 | 0.080 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1538 | 0.080 |
Why?
|
Specialization | 1 | 2013 | 777 | 0.080 |
Why?
|
Risk Factors | 11 | 2023 | 72145 | 0.080 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2008 | 62 | 0.080 |
Why?
|
Conjugation, Genetic | 1 | 2008 | 126 | 0.080 |
Why?
|
Paternal Exposure | 2 | 2005 | 89 | 0.080 |
Why?
|
Sleep | 2 | 2021 | 4604 | 0.080 |
Why?
|
Algorithms | 6 | 2023 | 13853 | 0.080 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2013 | 1121 | 0.080 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 839 | 0.080 |
Why?
|
Evoked Potentials, Auditory | 1 | 2010 | 525 | 0.080 |
Why?
|
Genes, Dominant | 3 | 2016 | 880 | 0.070 |
Why?
|
Trichloroethylene | 1 | 2006 | 13 | 0.070 |
Why?
|
Cocaine | 3 | 2019 | 1008 | 0.070 |
Why?
|
Proteins | 1 | 2022 | 6096 | 0.070 |
Why?
|
Jaw | 2 | 2018 | 96 | 0.070 |
Why?
|
Cerebrovascular Circulation | 3 | 2023 | 2732 | 0.070 |
Why?
|
DNA, Ribosomal | 1 | 2008 | 289 | 0.070 |
Why?
|
Program Development | 1 | 2013 | 1314 | 0.070 |
Why?
|
Acoustic Stimulation | 3 | 2019 | 1216 | 0.070 |
Why?
|
Causality | 1 | 2013 | 1265 | 0.070 |
Why?
|
Retina | 1 | 2017 | 2611 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7770 | 0.070 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15108 | 0.070 |
Why?
|
Anticonvulsants | 1 | 2016 | 1914 | 0.070 |
Why?
|
Intelligence Tests | 1 | 2007 | 505 | 0.070 |
Why?
|
Homozygote | 2 | 2022 | 1777 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2015 | 1155 | 0.070 |
Why?
|
Cerebral Arteries | 1 | 2008 | 492 | 0.070 |
Why?
|
Genetic Markers | 1 | 2012 | 2633 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2012 | 814 | 0.070 |
Why?
|
Severity of Illness Index | 5 | 2018 | 15530 | 0.070 |
Why?
|
Checklist | 1 | 2013 | 830 | 0.070 |
Why?
|
Pedigree | 2 | 2019 | 4646 | 0.070 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2008 | 962 | 0.070 |
Why?
|
Contrast Media | 4 | 2019 | 5295 | 0.070 |
Why?
|
Abscisic Acid | 1 | 2005 | 38 | 0.070 |
Why?
|
Radiography | 3 | 2013 | 7010 | 0.070 |
Why?
|
Microscopy, Electron | 1 | 2009 | 2645 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2195 | 0.070 |
Why?
|
Species Specificity | 2 | 2008 | 2479 | 0.070 |
Why?
|
Reaction Time | 3 | 2023 | 2092 | 0.070 |
Why?
|
Solvents | 1 | 2006 | 302 | 0.070 |
Why?
|
Lip | 2 | 2018 | 195 | 0.070 |
Why?
|
Models, Biological | 4 | 2016 | 9581 | 0.070 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2006 | 249 | 0.060 |
Why?
|
Polysomnography | 1 | 2012 | 1772 | 0.060 |
Why?
|
Face | 1 | 2011 | 993 | 0.060 |
Why?
|
Neurology | 1 | 2013 | 762 | 0.060 |
Why?
|
Trigeminal Nerve | 1 | 2006 | 249 | 0.060 |
Why?
|
Photoperiod | 1 | 2005 | 136 | 0.060 |
Why?
|
Drug Resistance, Bacterial | 1 | 2012 | 1032 | 0.060 |
Why?
|
Microglia | 3 | 2022 | 1261 | 0.060 |
Why?
|
Gene Expression Regulation, Plant | 1 | 2005 | 201 | 0.060 |
Why?
|
Menopause | 2 | 2023 | 1621 | 0.060 |
Why?
|
Program Evaluation | 1 | 2013 | 2485 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3769 | 0.060 |
Why?
|
Education | 1 | 2007 | 543 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2016 | 2838 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2014 | 1617 | 0.060 |
Why?
|
Tongue | 2 | 2018 | 406 | 0.060 |
Why?
|
Inclusion Bodies | 2 | 2015 | 279 | 0.060 |
Why?
|
Mass Spectrometry | 2 | 2022 | 2203 | 0.060 |
Why?
|
Arabidopsis Proteins | 1 | 2005 | 262 | 0.060 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2008 | 563 | 0.060 |
Why?
|
Monoamine Oxidase | 1 | 2024 | 178 | 0.060 |
Why?
|
Monocytes | 1 | 2013 | 2593 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 2736 | 0.060 |
Why?
|
Reproduction | 2 | 2005 | 668 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 7901 | 0.060 |
Why?
|
Boston | 3 | 2023 | 9305 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2020 | 77098 | 0.060 |
Why?
|
Food Deprivation | 1 | 2003 | 116 | 0.060 |
Why?
|
Benzene Derivatives | 1 | 2003 | 54 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2275 | 0.060 |
Why?
|
Toxicity Tests | 1 | 2003 | 121 | 0.060 |
Why?
|
Regional Blood Flow | 1 | 2006 | 1525 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3526 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2010 | 1827 | 0.050 |
Why?
|
Disease Management | 1 | 2013 | 2450 | 0.050 |
Why?
|
Peptide Mapping | 1 | 2022 | 263 | 0.050 |
Why?
|
Larynx | 2 | 2018 | 492 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2012 | 7153 | 0.050 |
Why?
|
Arabidopsis | 1 | 2005 | 459 | 0.050 |
Why?
|
Melanins | 1 | 2024 | 288 | 0.050 |
Why?
|
Comorbidity | 1 | 2016 | 10372 | 0.050 |
Why?
|
Sexual Maturation | 1 | 2003 | 265 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2023 | 402 | 0.050 |
Why?
|
Maternal Exposure | 2 | 2005 | 961 | 0.050 |
Why?
|
Bacteria | 1 | 2012 | 2102 | 0.050 |
Why?
|
Neurotoxicity Syndromes | 1 | 2005 | 290 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2714 | 0.050 |
Why?
|
Prevalence | 3 | 2022 | 15194 | 0.050 |
Why?
|
Inhalation Exposure | 4 | 2005 | 443 | 0.050 |
Why?
|
ROC Curve | 3 | 2014 | 3528 | 0.050 |
Why?
|
Carotid Artery, Common | 1 | 2022 | 183 | 0.050 |
Why?
|
Societies, Medical | 1 | 2013 | 3740 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3611 | 0.050 |
Why?
|
Phylogeny | 1 | 2008 | 2797 | 0.050 |
Why?
|
Calcium-Binding Proteins | 1 | 2005 | 1081 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12344 | 0.050 |
Why?
|
Carcinogens | 1 | 2003 | 466 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2013 | 3527 | 0.050 |
Why?
|
Phantoms, Imaging | 2 | 2020 | 2466 | 0.040 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2002 | 419 | 0.040 |
Why?
|
Adolescent | 8 | 2022 | 85649 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2008 | 4801 | 0.040 |
Why?
|
Quality Control | 1 | 2022 | 841 | 0.040 |
Why?
|
Spinal Cord | 1 | 2008 | 1807 | 0.040 |
Why?
|
Rats | 7 | 2020 | 24265 | 0.040 |
Why?
|
Latin America | 1 | 2020 | 381 | 0.040 |
Why?
|
Sex Factors | 3 | 2019 | 10392 | 0.040 |
Why?
|
Motion | 1 | 2023 | 797 | 0.040 |
Why?
|
Carotid Artery, Internal | 1 | 2022 | 445 | 0.040 |
Why?
|
Rats, Inbred Strains | 3 | 2005 | 2191 | 0.040 |
Why?
|
Light | 1 | 2005 | 1374 | 0.040 |
Why?
|
Hormones | 1 | 2023 | 884 | 0.040 |
Why?
|
Half-Life | 1 | 2020 | 658 | 0.040 |
Why?
|
Respiratory System | 1 | 2002 | 555 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2021 | 579 | 0.040 |
Why?
|
Frontal Lobe | 2 | 2017 | 1407 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2016 | 2885 | 0.040 |
Why?
|
Glycopeptides | 1 | 2020 | 224 | 0.040 |
Why?
|
Auditory Perception | 1 | 2023 | 568 | 0.040 |
Why?
|
Hemorrhage | 2 | 2022 | 3461 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6171 | 0.040 |
Why?
|
Time Factors | 2 | 2017 | 40054 | 0.040 |
Why?
|
Phenanthrolines | 1 | 2017 | 55 | 0.040 |
Why?
|
Self Report | 2 | 2019 | 3548 | 0.040 |
Why?
|
Death | 1 | 2022 | 675 | 0.040 |
Why?
|
Photic Stimulation | 2 | 2016 | 2027 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 13814 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2020 | 699 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2017 | 62966 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20086 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2022 | 952 | 0.040 |
Why?
|
Diagnosis | 1 | 2017 | 154 | 0.040 |
Why?
|
Extracellular Space | 1 | 2018 | 594 | 0.040 |
Why?
|
Radioligand Assay | 1 | 2017 | 379 | 0.040 |
Why?
|
No-Observed-Adverse-Effect Level | 2 | 2006 | 25 | 0.040 |
Why?
|
Brain Stem | 1 | 2022 | 844 | 0.040 |
Why?
|
Tritium | 1 | 2017 | 746 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 18112 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1723 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 2016 | 379 | 0.030 |
Why?
|
Speech Production Measurement | 1 | 2016 | 98 | 0.030 |
Why?
|
Body Weight | 2 | 2005 | 4664 | 0.030 |
Why?
|
Voice | 1 | 2019 | 259 | 0.030 |
Why?
|
TDP-43 Proteinopathies | 1 | 2015 | 38 | 0.030 |
Why?
|
Logistic Models | 3 | 2016 | 13403 | 0.030 |
Why?
|
Biopsy | 1 | 2007 | 6756 | 0.030 |
Why?
|
Electric Power Supplies | 1 | 2015 | 99 | 0.030 |
Why?
|
Delirium | 1 | 2006 | 1608 | 0.030 |
Why?
|
Independent Living | 1 | 2019 | 564 | 0.030 |
Why?
|
Learning | 2 | 2020 | 1705 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6474 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8297 | 0.030 |
Why?
|
Limbic System | 1 | 2017 | 426 | 0.030 |
Why?
|
Fourier Analysis | 1 | 2015 | 447 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3133 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2015 | 498 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2020 | 972 | 0.030 |
Why?
|
Rats, Inbred F344 | 2 | 2006 | 862 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5062 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6534 | 0.030 |
Why?
|
Drug Discovery | 1 | 2021 | 1057 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9639 | 0.030 |
Why?
|
HLA-D Antigens | 1 | 2013 | 134 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2020 | 1025 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2010 | 18006 | 0.030 |
Why?
|
Individuality | 1 | 2014 | 303 | 0.030 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2012 | 141 | 0.030 |
Why?
|
Language Tests | 1 | 2013 | 200 | 0.030 |
Why?
|
Mice | 5 | 2023 | 81045 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2016 | 2335 | 0.030 |
Why?
|
Survival Analysis | 2 | 2015 | 10248 | 0.030 |
Why?
|
Calcium | 1 | 2005 | 5753 | 0.030 |
Why?
|
Rest | 1 | 2017 | 900 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2167 | 0.030 |
Why?
|
Calibration | 1 | 2014 | 815 | 0.030 |
Why?
|
Administration, Inhalation | 2 | 2006 | 1104 | 0.030 |
Why?
|
Somatosensory Cortex | 1 | 2016 | 527 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12958 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2533 | 0.030 |
Why?
|
Fatigue | 1 | 2019 | 1526 | 0.030 |
Why?
|
Massachusetts | 2 | 2015 | 8662 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 2015 | 1144 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1989 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2015 | 939 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1864 | 0.030 |
Why?
|
Levodopa | 1 | 2012 | 218 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 2003 | 0.020 |
Why?
|
Cadaver | 1 | 2015 | 1333 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2948 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2012 | 183 | 0.020 |
Why?
|
Dextrans | 1 | 2013 | 592 | 0.020 |
Why?
|
Electroencephalography | 2 | 2020 | 6142 | 0.020 |
Why?
|
Anisotropy | 1 | 2014 | 1265 | 0.020 |
Why?
|
Psychoacoustics | 1 | 2010 | 56 | 0.020 |
Why?
|
Family Health | 1 | 2016 | 1282 | 0.020 |
Why?
|
Safety | 1 | 2015 | 1185 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4200 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 4029 | 0.020 |
Why?
|
Delusions | 1 | 2012 | 300 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2023 | 4465 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6608 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1727 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 975 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12220 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2012 | 931 | 0.020 |
Why?
|
Salmo salar | 1 | 2008 | 8 | 0.020 |
Why?
|
Edwardsiella | 1 | 2008 | 6 | 0.020 |
Why?
|
Water Pollutants, Chemical | 1 | 2012 | 311 | 0.020 |
Why?
|
Aeromonas hydrophila | 1 | 2008 | 10 | 0.020 |
Why?
|
Models, Statistical | 1 | 2023 | 5100 | 0.020 |
Why?
|
Integrons | 1 | 2008 | 20 | 0.020 |
Why?
|
Electrodes | 1 | 2010 | 615 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1188 | 0.020 |
Why?
|
Sequence Homology | 1 | 2008 | 203 | 0.020 |
Why?
|
Gene Order | 1 | 2008 | 176 | 0.020 |
Why?
|
Internationality | 1 | 2013 | 1002 | 0.020 |
Why?
|
Mothers | 1 | 2018 | 2163 | 0.020 |
Why?
|
Cost of Illness | 1 | 2017 | 1852 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4187 | 0.020 |
Why?
|
Organ of Corti | 1 | 2006 | 84 | 0.020 |
Why?
|
Information Dissemination | 1 | 2015 | 1100 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15494 | 0.020 |
Why?
|
Nucleotidyltransferases | 1 | 2008 | 220 | 0.020 |
Why?
|
Germination | 1 | 2005 | 12 | 0.020 |
Why?
|
Plants, Genetically Modified | 1 | 2005 | 110 | 0.020 |
Why?
|
Seeds | 1 | 2005 | 105 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12242 | 0.020 |
Why?
|
United States | 1 | 2013 | 69693 | 0.020 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2006 | 247 | 0.020 |
Why?
|
Osmotic Pressure | 1 | 2005 | 151 | 0.020 |
Why?
|
Calmodulin | 1 | 2005 | 209 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2015 | 2049 | 0.020 |
Why?
|
Europe | 1 | 2011 | 3339 | 0.020 |
Why?
|
Ion Transport | 1 | 2005 | 320 | 0.020 |
Why?
|
DNA Transposable Elements | 1 | 2008 | 748 | 0.020 |
Why?
|
Testosterone Propionate | 1 | 2003 | 5 | 0.010 |
Why?
|
Seminiferous Tubules | 1 | 2003 | 26 | 0.010 |
Why?
|
Software | 1 | 2018 | 4434 | 0.010 |
Why?
|
Seminal Vesicles | 1 | 2003 | 101 | 0.010 |
Why?
|
Language | 1 | 2013 | 1458 | 0.010 |
Why?
|
Maze Learning | 1 | 2005 | 478 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2008 | 1465 | 0.010 |
Why?
|
Microsomes, Liver | 1 | 2003 | 175 | 0.010 |
Why?
|
Canada | 1 | 2008 | 2061 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4328 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2008 | 1871 | 0.010 |
Why?
|
Motor Cortex | 1 | 2009 | 984 | 0.010 |
Why?
|
Nervous System | 1 | 2005 | 553 | 0.010 |
Why?
|
Epididymis | 1 | 2003 | 227 | 0.010 |
Why?
|
S Phase | 1 | 2003 | 423 | 0.010 |
Why?
|
Mixed Function Oxygenases | 1 | 2003 | 272 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3493 | 0.010 |
Why?
|
Risk Assessment | 2 | 2019 | 23320 | 0.010 |
Why?
|
Psychometrics | 1 | 2010 | 2999 | 0.010 |
Why?
|
Orchiectomy | 1 | 2003 | 466 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 2837 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2012 | 2749 | 0.010 |
Why?
|
Kidney Tubules, Proximal | 1 | 2003 | 417 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2006 | 1015 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2003 | 1827 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23387 | 0.010 |
Why?
|
Blood Pressure | 1 | 2015 | 8541 | 0.010 |
Why?
|
Respiratory Mucosa | 1 | 2003 | 427 | 0.010 |
Why?
|
Nasal Mucosa | 1 | 2002 | 373 | 0.010 |
Why?
|
Bronchi | 1 | 2003 | 840 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7716 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2002 | 13019 | 0.010 |
Why?
|
Isoenzymes | 1 | 2002 | 1725 | 0.010 |
Why?
|
Liver | 2 | 2003 | 7470 | 0.010 |
Why?
|
Genomics | 1 | 2012 | 5692 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2018 | 15244 | 0.010 |
Why?
|
Escherichia coli | 1 | 2008 | 4214 | 0.010 |
Why?
|
Prostate | 1 | 2003 | 1764 | 0.010 |
Why?
|
Androgen Antagonists | 1 | 2003 | 1350 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2005 | 3617 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10943 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2005 | 9410 | 0.010 |
Why?
|
DNA | 1 | 2003 | 7289 | 0.010 |
Why?
|
Kidney | 1 | 2003 | 7167 | 0.000 |
Why?
|
Apoptosis | 1 | 2003 | 9715 | 0.000 |
Why?
|
Lung | 1 | 2002 | 9826 | 0.000 |
Why?
|